By vgreene, 27 September, 2017 Evidence for CA risks NCI1 notes conflicting evidence regarding risks of various CAs
By vgreene, 27 September, 2017 Anorexia nervosa Insufficient no evidence I N that cannabinoids are effective 1
By vgreene, 27 September, 2017 HIV AIDS assoc low appetite and wt loss Limited evidence L that cannabis and oral cannabinoids are effective for uarr appetite and darr wt loss 1
By vgreene, 27 September, 2017 CA assoc anorexia cachexia syndrome Insufficient no evidence I N for effectiveness of cannabinoids 1 No published studies on inhaled cannabis for appetite in CA pts 2
By vgreene, 27 September, 2017 Nausea of pregnancy Marijuana use not recommended during pregnancy linked to lower birth wt and uarr risk of preterm birth may also affect fetal brain development 5
By vgreene, 27 September, 2017 IBS sx. Evidence for effectiveness of dronabinol is insufficient/none [I/N], per NAS1
By vgreene, 27 September, 2017 Anorexia nervosa. Evidence for effectiveness of cannabinoids is insufficient/none [I/N], per NAS1
By vgreene, 27 September, 2017 HIV/AIDS-assoc low appetite & wt loss: Evidence for effectiveness of cannabis & oral cannabinoids for ↑ appetite ↓ wt loss is limited [L], per NAS1
By vgreene, 27 September, 2017 CA-assoc anorexia/cachexia syndrome. Evidence for effectiveness on cannabinoids is insufficient/none [I/N], per NAS.1 NCI2 notes no published studies on inhaled cannabis for appetite in CA pts
